Focal adhesion kinase (FAK) has been implicated in the regulation of cell migration. In addition, FAK expression is increased in a number of highly metastatic tumor cell lines. Therefore, we investigated the role of FAK in regulating migration of prostate carcinoma cell lines with increasing metastatic potential. We show that highly tumorigenic PC3 and DU145 cells exhibit intrinsic migratory capacity, while poorly tumorigenic LNCaP cells require a stimulus to migrate. Increased metastatic potential of PC3 and DU145 cells correlates with increased FAK expression, overall tyrosine phosphorylation and activity, as measured by autophosphorylation of tyrosine 397. However, in PC3 and DU145 cells, FAK autophosphorylation is adhesion dependent whereas a second site of tyrosine phosphorylation, tyrosine 861, a Src speci®c site, is uncoupled from adhesion-dependent signaling events. Finally, inhibiting the FAK/Src signal transduction pathway by over expressing FRNK (Focal adhesion kinase-Related Non-Kinase), an inhibitor of FAK activation, or treatment with PP2, a Src family kinase inhibitor, signi®cantly inhibited migration of prostate carcinoma cell lines, demonstrating that tumor cell migration continues to be dependent on signals emanating from this pathway.
Introduction
Tumor cell progression toward increasing metastatic potential is a complex, multi-step process that involves, among other things, the ability of typically non-motile cells to detach from native extracellular matrix (ECM) and migrate to distal sites. While it is clear that genetic changes leading to alteration of cellular function underscore metastasis, the molecular mechanisms that regulate tumor migration are poorly understood.
Cell migration is a multi-step process that requires repeated adhesion to and detachment from ECM. These events are largely mediated by heterodimeric transmembrane receptors, integrins, which upon engagement with components of the ECM reorganize to form adhesion complexes termed focal adhesions/focal complexes. In addition to linking structural components of the cytoskeleton to the underlying matrix, focal adhesions/focal complexes organize a signal transduction cascade initiated by integrin-mediated recognition of ECM components (e.g. ®bronectin, laminin, collagen). Indeed, integrin clustering results in increased protein tyrosine phosphorylation (Guan et al., 1991; Kornberg et al., 1991) . Among the proteins phosphorylated as a result of integrin clustering is a protein tyrosine kinase localized within the focal adhesion, Focal Adhesion Kinase or FAK (Guan, 1992; Kornberg et al., 1992; Lipfert et al., 1992; Miyamoto et al., 1995) . Upon integrin engagement, FAK becomes phosphorylated on tyrosine 397, creating a high anity binding site for Src and Src family kinases (Schaller et al., 1994) . The FAK/Src complex, in turn, is thought to mediate phosphorylation of several associated focal adhesion proteins as well as additional sites on FAK including tyrosines 576/577 and 861 (Calalb et al., 1995; Calalb et al., 1996; Polte and Hanks, 1995; Schaller and Parsons, 1995) .
Since integrins themselves lack catalytic activity, the stimulation of FAK kinase activity upon integrin occupancy suggests a role for FAK in the signaling that underlies integrin-mediated cell adhesion and migration. Indeed, the results from several experimental systems provide evidence of a role for FAK in cell adhesion and migration. Blocking FAK activation by over expressing the C-terminal, non-catalytic domain of FAK, FRNK (FAK-Related Non-Kinase), results in a delay in cell spreading on ®bronectin (Richardson and Parsons, 1996) and prevents migration of cells into a wound (Gilmore and Romer, 1996) . Additionally, cells derived from mouse embryos de®cient in FAK expression exhibit reduced ®bronec-tin-stimulated motility (Ilic et al., 1995; Owen et al., 1999; Sieg et al., 1999) . Conversely, stable over expression of FAK in Chinese hamster ovary cells stimulates cell migration on ®bronectin (Cary et al., 1996) .
Src association with FAK is critical for regulating migration. FAK null ®broblasts re-engineered to express a Y397F FAK mutant are de®cient in haptotaxis whereas wild type FAK expression promotes haptotactic migration (Sieg et al., 1999) . Additionally, ®broblasts lacking Src, Fyn and Yes expression are defective in ®bronectin-stimulated haptotaxis but not platelet derived growth factor (PDGF)-stimulated chemotaxis (Klinghoer et al., 1999) . These observations support a role for a FAK/ Src complex in the regulation of haptotactic migration.
Elevated FAK expression has been observed in a number of human cancer cell lines with increasing tumorigenic potential (Fox et al., 1999; Han et al., 1997; Judson et al., 1999; Owens et al., 1995 Owens et al., , 1996 Tremblay et al., 1996a) . Speci®cally, two highly aggressive, invasive human prostate carcinoma cell lines originally obtained from metastatic lesions to bone (PC3) and brain (DU145) exhibit elevated FAK expression and activity compared to the non-invasive, poorly tumorigenic LNCaP cells (Tremblay et al., 1996a, b) , obtained from metastases to the lymph node. While FAK expression and activity are elevated in more aggressive tumors, it is not clear whether FAK activity remains regulated by integrin engagement or if FAK mediated signaling is still required for migration of these tumor cells. Therefore, we investigated the role of FAK in regulating a key component of cellular metastasis, namely cell migration. We show that increasing metastatic potential of prostate carcinoma cell lines correlates with an increase in intrinsic migratory capacity. As reported by others (Tremblay et al., 1996a,b; Zheng et al., 1999) , we show that increased metastatic potential correlates with increased FAK expression, overall tyrosine phosphorylation and activity, as measured by autophosphorylation of tyrosine 397. We also show that FAK autophosphorylation is adhesion dependent in PC3 and DU145, whereas a second site of major tyrosine phosphorylation, tyrosine 861, a Src speci®c site, is uncoupled from adhesion-dependent signaling events. Finally, we show that inhibition of the FAK/Src signal transduction pathway signi®cantly inhibited migration of prostate carcinoma cell lines, demonstrating that tumor cell migration continues to be dependent on signals emanating from this pathway.
Results
It is reported that increased ectopic FAK expression correlates with increased levels of cell migration (Cary et al., 1996) . Increased metastatic potential of prostate cell lines is accompanied by an increase in cell migration in vitro (Mohler et al., 1988) . Using a Boyden chamber assay, we assessed the ability of prostate carcinoma cell lines with diering tumorigenic potentials (LNCaP, PC3, and DU145) to undergo unstimulated chemokinesis, serum-stimulated chemokinesis, or extracellular matrix induced haptotaxis. As shown in Figure 1a , LNCaP cells migrated poorly without the addition of serum. Increasing concentrations of serum stimulated migration in a dosedependent manner. The inability of LNCaP cells to migrate in the absence of serum was not due to a de®ciency in their ability to adhere to a substrate (data not shown). Indeed, LNCaP cells readily migrated toward extracellular matrix components, ®bronectin and laminin, in the absence of serum (Figure 2a) . Dose-dependent migration toward ®bronectin reached maximal levels at 10 mg/ml while migration toward human laminin continued to increase up to 30 mg/ml. Contrary to a previous report (Zheng et al., 1999) , we found that LNCaP cells migrated eciently toward 5 mg/ml vitronectin. However, the LNCaP cells used in the present studies express both a v b 3 and a v b 5 and blocking antibodies to a v b 5 but not a v b 3 prevented attachment of LNCaP cells to vitronectin (M Edlund and L Chung, personal communication) . Together, these data indicate that poorly tumorigenic, LNCaP cells require a stimulatory signal, either serum or an extracellular matrix component, to migrate.
In contrast to LNCaP cells, PC3 and DU145 cells exhibited signi®cant migratory capacity (Figure 1b, c) in the absence of added factors. While these cells displayed augmented basal chemokinetic activity, both PC3 and DU145 cells were capable of responding to stimuli (Figures 1 and 2 ). Low concentrations of serum (1%) stimulated maximal (approximately 2 ± 3-fold increase) migration of both PC3 and DU145 cells, while higher concentrations failed to increase migration signi®cantly above unstimulated levels (Figure 1b,c) . Analysis of haptotactic migration revealed that PC3 cells migrated toward ®bronectin in a dose-dependent manner reaching a maximal 2 ± 3-fold stimulation of migration between 3 and 10 mg/ml (Figure 2b ). Dose dependent migration of PC3 cells to human laminin was more robust, increasing approximately 6 ± 12-fold and reaching a maximum at 10 mg/ml ( Figure 2b ). As previously reported (Zheng et al., 1999) , 5 mg/ml vitronectin stimulated an approximate fourfold increase in migration (Figure 2b ). Due to the high level of chemokinesis in DU145 cells, we observed at best, a modest twofold increase in migration in response to ®bronectin, laminin and vitronectin (Figure 2c) .
FAK has been implicated in regulating migration of a number of cell types (Cary et al., 1996; Fox et al., 1999; Gilmore and Romer, 1996; Ilic et al., 1995; Owen et al., 1999; Richardson and Parsons, 1996; Sieg et al., 1998 Sieg et al., , 1999 Zheng et al., 1999) . Moreover increased FAK expression correlates with increasing metastatic potential of tumor cell lines (Fox et al., 1999; Han et al., 1997; Judson et al., 1999; Owens et al., 1995 Owens et al., , 1996 Tremblay et al., 1996a) . Therefore, we examined the level of FAK expression in each of the prostate cancer cell lines. As shown in Figure 3a, (Figure 3b) .
Because PC3 and DU145 cells exhibited high levels of FAK and concomitantly increased migration in the absence of added factors (e.g., serum or matrix proteins), we determined whether FAK activation remained dependent upon adhesion. LNCaP, PC3 and DU145 cells were removed from culture dishes, placed in suspension for 60 min and allowed to reattach to ®bronectin-coated dishes for increasing periods of time. FAK was immunoprecipitated from cell extracts and tyrosine phosphorylation was assessed by immunoblotting with anti-phosphotyrosine antibodies. As shown in Figure 3c , FAK tyrosine phosphorylation was signi®cantly reduced in suspended LNCaP cells ( Figure 3c , lane 2), an observation similar to that reported for cultured ®broblasts (Burridge et al., 1992; Kornberg et al., 1992) . Replating LNCaP cells on ®bronectin resulted in increased tyrosine phosphorylation of FAK within 30 min which remained elevated up to 90 min after plating (Figure 3c , lanes 3 ± 5). Similar results were obtained when cells were replated on human laminin or vitronectin (data not shown). In contrast, PC3 or DU145 cells held in suspension for 60 min failed to exhibit a reduction in FAK tyrosine phosphorylation (Figure 3c , lanes 7 and 11). Subsequent plating of PC3 or DU145 cells on ®bronectin had no eect on the levels of tyrosine phosphorylated FAK (Figure 3c, lanes 8, 9, 12, 13) . In fact, prolonged suspension (up to 6 h) had no eect on the extent of FAK tyrosine phosphorylation in PC3 or DU145 cells (Figure 3d ).
Integrin clustering stimulates autophosphorylation of FAK predominantly at tyrosine 397 (Lipfert et al., 1992; Schaller et al., 1994) , the recruitment of Src family kinases and subsequent phosphorylation of FAK at other sites, including tyrosines 576/577, 861 and 925 (Calalb et al., 1995 (Calalb et al., , 1996 ; Schlaepfer et al., Vitronectin-stimulated migration data were obtained from independent experiments while ®bronectin and laminin migration data are from the same experiment for each cell type. Similar results were observed in three independent experiments 1994). Therefore, we directly examined phosphorylation of these sites using phosphorylation speci®c antibodies. Whole cell lysates from LNCaP, PC3 and DU145 cell lines were prepared from adherent cells, cells held in suspension for 60 min, or cells suspended for 60 min and allowed to re-attach to ®bronectin coated dishes for 30 or 90 min. As shown in Figure 4 , FAK phosphorylation at tyrosine 397 decreased in all three cell types placed in suspension ( Figure 4a , lanes 2, 6 and 10). FAK tyrosine 397 phosphorylation was re-established when LNCaP, PC3 and DU145 cells were plated on ®bronectin (Figure 4a, lanes 3, 4, 7, 8, 11 and 12) as well as human laminin or vitronectin (data not shown). While FAK tyrosine 397 phosphorylation was regulated by integrin-mediated signals in all three cell lines, the level of FAK tyrosine 397 phosphorylation was elevated in adherent PC3 and DU145 cells compared to adherent LNCaP ( Figure 4a , lanes 1, 5 and 9). Indeed, adjusting for dierences in protein expression levels, phosphorylation of tyrosine 397 was approximately 7 ± 10-fold higher in PC3 cells than LNCaP cells and approximately twofold greater in DU145 cells than PC3 (data not shown). These observations indicate that, while FAK expression and activity were elevated in PC3 and DU145 cells compared to LNCaP cells, FAK tyrosine 397 phos- Western blot analysis of LNCaP, PC3 and DU145 cell lysates was used to compare FAK expression levels. 100 mg of LNCaP lysate (lanes 6 and 12) were loaded in parallel with 5, 10, 25, 50 and 100 mg of PC3 lysate (lanes 1 ± 5) or DU145 lysate (lanes 7 ± 11) on a 10% SDS ± PAGE and blotted for FAK with an anti-human FAK Cterminal antibody (Pharminogen). (c) FAK was immunoprecipitated (see Materials and methods) from LNCaP (lanes 1 ± 5), PC3 (lanes 6 ± 9), or DU145 (lanes 10 ± 13) cells that were continuously adherent (lanes 1, 6 and 10), placed in suspension for 60 min (lanes 2, 7 and 11) or allowed to adhere for increasing periods of time to dishes coated with 40 mg/ml ®bronectin (lanes 3 ± 5, 8, 9, 12 and 13). (d) FAK was immunoprecipitated from PC3 or DU145 cells that were adherent (lanes 1 and 7) or suspended for 0.5, 1, 2, 4 or 6 h (lanes 2 ± 6 and 8 ± 11). For (c) and (d), immunoprecipitates were blotted for phosphotyrosine (pTyr) using 4G10. The ®lters were stripped and probed for FAK using anti-FAK monoclonal antibody 2A7 to insure equal loading phorylation is regulated by cellular adhesion in all three cell types. Furthermore, the increased FAK phosphorylation in suspended PC3 and DU145 cells must re¯ect phosphorylation at additional tyrosine residues.
Phosphophorylation speci®c antibodies were used to assess the dierential phosphorylation of FAK on tyrosines 576/577, 861 and 925 following replating onto ®bronectin. Whereas FAK phosphorylation on tyrosine 925 has been reported in v-src transformed cells (Schlaepfer et al., 1994) , little phosphorylation at this site was evident in any of the prostate cell lines (data not shown). Similarly, only low levels of phosphorylation of tyrosines 576/577 were detectable above background non-speci®c binding (data not shown). In LNCaP cells, phosphorylation of tyrosine 861 showed a similar pattern as phosphorylation of tyrosine 397, decreased in suspended LNCaP cells (Figure 4b , lane 2) and increased upon replating on ®bronectin (Figure 4b , lanes 3 and 4). However, FAK phosphorylation at tyrosine 861 remained elevated in suspended PC3 and DU145 cells (Figure 4b , lanes 6 and 10) and was unaected by subsequent plating on ®bronectin (Figure 4b, lanes 7, 8, 11 and 12 ). In addition, the level of steady state phosphorylation of FAK tyrosine 861 in adherent PC3 was approximately ®ve times greater than that observed in adherent LNCaP cells when normalized to protein expression (Figure 4b , lanes 1, 5 and 9). FAK tyrosine 861 phosphorylation was comparable between DU145 and LNCaP cells (data not shown). These data suggest that phosphorylation of tyrosine 861 is uncoupled from adhesion signaling in both PC3 and DU145 cells and, as a result, phosphorylation of FAK tyrosine 861 accounts for a majority of the signal observed in suspended PC3 and DU145 cells (Figure 3) .
Because FAK tyrosine 861 has been shown to be a site for Src-directed phosphorylation (Calalb et al., 1995 (Calalb et al., , 1996 , we examined the role of Src family kinases on FAK phosphorylation in prostate carcinoma cells. Adherent PC3 and DU145 cells were treated with a Src-speci®c inhibitor, PP2 (Hanke et al., 1996) , or the inactive congener, PP3 for 90 min and the level of FAK phosphorylation was examined using site speci®c phosphorylation antibodies. As shown in Figure 5 , FAK phosphorylation on tyrosine 861 was virtually eliminated in adherent PC3 and DU145 cells following treatment with 10 mM PP2, while 10 mM PP3 had no eect. FAK phosphorylation on tyrosine 397 was unaected by PP2 treatment (Figure 5a ), underscoring the speci®city of the PP2 inhibitor. These data support a role for Src family kinases in the phosphorylation of tyrosine 861 and suggest that the phosphorylation of tyrosine 861 may not be regulated by integrin dependent signaling pathways.
Inhibition of the FAK/Src signal transduction pathway blocks migration of prostate carcinoma cell lines
To assess the contribution of the FAK/Src signal transduction pathway in the regulation of prostate cell migration, we tested the eects of FAK and Src Figure 4 Adhesion-dependent FAK phosphorylation at Y397 and Y861. LNCaP, PC3, and DU145 lysates were generated from adherent cells (a; lanes 1, 5 and 9), cells placed in suspension for 1 h (S; lanes 2, 6 and 10), or cells suspended for 1 h and allowed to attach to ®bronectin (FN) for 30 or 90 min (lanes 3, 4, 7, 8, 11 and 12) . 100 mg of each lysate were blotted for FAK phosphotyrosine 397 (a; p-Y397:IB) or FAK phosphotyrosine 861 (b; p-Y861:IB). The ®lters were stripped and blotted for FAK using anti-human FAK C-Term (FAK:IB) inhibitors on cell migration. Ectopic over expression of FRNK has been shown to inhibit FAK activation in a number of dierent cell types (Gilmore and Romer, 1996; Richardson et al., 1997; Richardson and Parsons, 1996; Sieg et al., 1999) . To inhibit FAK signaling, LNCaP, PC3 and DU145 cells were infected with adenoviruses engineered to express either GFP (GFP) or GFP-tagged FRNK (GFP ± FRNK). Adherent LNCaP, PC3, or DU145 cells were infected with GFP ± FRNK or GFP for 6 h prior to harvest and placement into transwell migration chambers. Cells were allowed to migrate for 24 h in the presence or absence of serum or toward ®bronectin, human laminin or vitronectin. As shown in Figure 6 , FRNK over expression inhibited migration of all prostate carcinoma cell lines. Table 1 summarizes the mean inhibition of migration induced by FRNK expression from three independent experiments performed in triplicate. Chemokinesis of PC3 and DU145 cells was inhibited approximately 60 ± 65% by GFP ± FRNK infection, while serum-stimulated migration of LNCaP, PC3 and DU145 was decreased by 70 ± 80% ( Figure 6 and Table 1 ). FRNK over expression inhibited ®bronectin-stimulated migration of LNCaP and PC3 cells by 70% and DU145 cells approximately 35% ( Figure 6 and Table 1 ). Migration toward laminin and vitronectin was also inhibited by GFP ± FRNK infection (data not shown). Control experiments showed that adenovirus-induced FRNK expression in prostate carcinoma cell lines signi®cantly reduced FAK phosphorylation on tyrosine 397 within 48 h of infection (Figure 6d) . Similarly, phosphorylation of FAK tyrosine 861 was reduced by GFP ± FRNK infection (Figure 6d ). Since FRNK contains a tyrosine corresponding to tyrosine 861 of FAK, we examined the phosphorylation status of GFP ± FRNK with anti-FAK phosphotyrosine 861. Indeed, we observed phosphorylation of GFP ± FRNK with the phosphotyrosine 861 antibody (Figure 6e) . However, the extent of phosphorylation of GFP ± FRNK relative to the level of expression was lower than the extent of FAK phosphorylation at this site (Figure 6d, e) and may be the result of over expression rather than a physiological response. Together, these results indicate that FRNK over expression negatively regulates prostate cell migration likely by blocking FAK activation and subsequent activity on downstream targets.
Integrin engagement and FAK activation leads to the recruitment and activation of Src (Schaller et al., 1994) , which in turn mediates the tyrosine phosphorylation of a number of proteins involved in the regulation of migration (Cary et al., 1998; Harte et al., 1996; Klemke et al., 1998; Nojima et al., 1995; Petit et al., 2000; Polte and Hanks, 1995; Turner et al., 1999; Vuori et al., 1996) . To assess the role of Src activity in regulating prostate cell migration, cells were allowed to migrate for 24 h in the presence or absence of serum, or towards ®bronectin in the presence or absence of 10 mM PP2. As shown in Figure 7 , PP2 inhibited the migration of all three cell types. Table 2 summarizes the per cent inhibition of migration by PP2 compiled from statistical analysis of three independent experiments performed in triplicate as described in Materials and methods. Serum-stimulated migration of LNCaP cells was inhibited approximately 90% while ®bronec-tin-stimulated migration was blocked by 75%. Similarly, unstimulated chemokinesis, serum-stimulated chemokinesis, and haptotaxis of PC3 cells was decreased approximately 80 ± 95% in the presence of PP2. Chemokinesis and serum-stimulated migration of DU145 cells was inhibited 65 ± 85%. However, ®bro-nectin-stimulated migration of DU145 cells was not signi®cantly blocked by PP2 treatment ( Table 2 ). The inhibition of migration caused by PP2 treatment was not due to decreased cell viability as determined using a MTT assay (data not shown). Furthermore, prostate carcinoma cells treated with 10 mM PP2 were able to attach and spread (data not shown). These observation provide strong support for a central role of FAK and Src in the regulation of prostate cell migration and further suggest that the increased FAK expression coupled with the constitutive phosphorylation of tyrosine 861 may be important for the increased migratory properties of highly tumorigenic prostate cells.
Discussion
In this report, we show a correlation between increasing cellular motility, alterations in FAK/Src signal transduction cascades and increasing tumorigenic potential of human prostate carcinoma cell lines. In accordance with reports by others (Tremblay et al., Figure 6 Migration of prostate carcinoma cells is inhibited by FRNK over expression. Adenovirus encoding the C-terminal domain of FAK (FRNK) fused to GFP or GFP alone were used to infect LNCaP, PC3 or DU145 cells. Migration was assessed using a Boyden chamber assay as described in Materials and methods. LNCaP (a) cells were stimulated to migrate in the presence of 10% serum or toward 10 mg/ml ®bronectin (FN). PC3 (b) or DU145 (c) cells were stimulated to migrate in the presence of 1% serum or toward 10 mg/ml ®bronectin (FN). Mock migration represents the unstimulated control. The data represent the mean+standard error for a single representative experiment performed in triplicate. Data from three independent experiments were analysed statistically as described in Materials and methods and are presented in Table 1 FAK autophosphorylation, while increased in PC3 and DU145 cells, remained dependent on cellular adhesion. However, Src-mediated phosphorylation of FAK on tyrosine 861 was uncoupled from adhesion signaling and, as a result, FAK was constitutively phosphorylated at this site in PC3 and DU145 cells. These observations indicate that FAK over expression coupled with increased phosphorylation of tyrosine 861 (by Src family kinases or an unknown, but PP2 sensitive kinase) promotes increased cell migration among the highly tumorigenic prostate cell lines. In support of this, inhibition of FAK and Src signaling pathways signi®cantly diminished migration of all three prostate carcinoma cell lines. Together, these data indicate that the FAK/Src signal transduction pathway is important in mediating migration of prostate tumor cell lines in vitro and suggest a potential therapeutic target to inhibit cellular metastasis.
An alteration in physiological constraints that enable typically non-motile epithelial cells to migrate is a hallmark of tumor invasion and metastasis. In these studies, we observed a correlation between increasing tumorigenic potential and intrinsic migratory capacity. Poorly tumorigenic LNCaP cells required serum or ECM stimulation to migrate. The failure of LNCaP cells to migrate was not due to their inability to adhere to or spread on ®bronectin. In contrast, the highly tumorigenic PC3 and DU145 cells migrate in the absence of external stimuli, although they remained responsive to chemotactic and haptotactic factors. These results suggest that tumor cells achieve increased motility through mechanisms that circumvent the requirement for exogenous motogenic factors. The requirement for serum or ECM to induce LNCaP motility is consistent with the idea that extracellular factors are required to activate intracellular signals necessary for motility in poorly tumorigenic cells. The Determined from three independent experiments performed in triplicate as described in Materials and methods. b Range within which we are 95% certain that the true value of this parameter lies Figure 7 Migration of prostate carcinoma cells is inhibited by PP2 treatment. LNCaP (a) cells were stimulated to migrate in the presence of 10% serum or toward 10 mg/ml ®bronectin (FN) in the presence or absence of 10 mM PP2. PC3 (b) or DU145 (c) cells were stimulated to migrate in the presence of 1% serum or toward 10 mg/ml ®bronectin (FN) in the presence or absence of 10 mM PP2. Mock migration represents the unstimulated control. The data represent the mean+standard error for a single representative experiment performed in triplicate. Data from three independent experiments were analysed statistically as described in Materials and methods and are presented in Table 2 Range within which we are 95% certain that the true value of this parameter lies Oncogene FAK/Src signaling in prostate carcinoma cell migration JK Slack et al absence of this requirement in PC3 and DU145 cells suggests that these cells have altered regulation of promigratory signaling cascades, which can occur through activation of autocrine signaling pathways or mutational activation of intracellular pathways that control cell movement.
Focal adhesion kinase is a signaling component that plays a central role in cell migration. FAK null ®broblasts are defective for cell migration (Ilic et al., 1995) . Similarly, as shown here and in other cell types, blocking endogenous FAK activation by over expressing FRNK inhibits cell motility (Gilmore and Romer, 1996; Sieg et al., 1999; Zheng et al., 1999; Richardson and Parsons, 1996) . Fibronectin-mediated migration is enhanced by over-expression of FAK (Cary et al., 1996) . As previously reported (Tremblay et al., 1996a,b) , we observed an increase in the expression and activity of FAK in PC3 and DU145 cells compared to LNCaP cells, which correlated with their ability to migrate in the absence of exogenous stimulation. FAK activity is regulated by integrinmediated cell adhesion as indicated by the adhesiondependent alterations in the phosphorylation of tyrosine 397 (Burridge et al., 1992; Guan, 1992; Kornberg et al., 1992; Lipfert et al., 1992; Schaller et al., 1994) . Similarly, the increase in FAK tyrosine 397 phosphorylation in PC3 and DU145 cells is regulated by cell adhesion, as manifested by the decrease in tyrosine 397 phosphorylation in cells in suspension. A novel observation in these studies is the constitutive phosphorylation of FAK on tyrosine 861, a major site of Src phosphorylation (Calalb et al., 1995 (Calalb et al., , 1996 . Phosphorylation of this site appears uncoupled from adhesion signaling, suggesting altered regulation of Src activity or the phosphatase responsible for dephosphorylation of tyrosine 861. Interestingly, the alteration of FAK tyrosine 861 phosphorylation did not re¯ect increases in Src expression or activation, as measured by activation-dependent phosphorylation of tyrosine 416 (data not shown). These observations suggest that an increase in FAK expression coupled with increased tyrosine phosphorylation of FAK on tyrosine 861 may contribute to the increased cell motility of highly tumorigenic prostate cancer cells. The functional signi®cance of tyrosine 861 phosphorylation is unknown at this time, but is under intense study.
A central role for FAK/Src signal transduction cascades in the regulation of prostate carcinoma cell migration comes from the observation that blocking these kinases inhibits cell motility. Blocking FAK activation by infecting prostate carcinoma cells with adenovirus engineered to express GFP-tagged FRNK eectively decreased migration of all three prostate carcinoma cell lines. Recently, FRNK over expression was shown to inhibit vitronectin, but not ®bronectin, -stimulated migration of LNCaP cells over expressing the integrin b 3 subunit (Zheng et al., 1999) . We ®nd that FRNK mediated inhibition of LNCaP migration is independent of ECM component since motility stimulated by ®bronectin, human laminin, and vitronectin were all eectively inhibited by FRNK expression (data not shown). Consistent with these observations, FRNK-mediated inhibition of FAK results in a delay in ®broblast cell spreading (Richardson and Parsons, 1996) and inhibition of ®broblast and endothelial cell migration (Gilmore and Romer, 1996; Richardson et al., 1997) . Ectopic FRNK expression in epithelial cells has been shown to induce apoptosis (Frisch et al., 1996) , which could account for the inhibition of migration. However, we do not observe signi®cant increases in apoptosis in the prostate carcinoma cell lines within 48 h post infection with GFP ± FRNK (Rovin, et al., in prep) .
Since FRNK expression blocks FAK phosphorylation of tyrosine 397 (Richardson et al., 1997; Richardson and Parsons, 1996) , which is a binding site required for the activation of Src family kinases (Schaller et al., 1994) , it is logical to assume that Src activity would also be inhibited by FRNK expression. A role for Src in prostate carcinoma cell migration is indicated by direct inhibition of migration following treatment with the Src-speci®c inhibitor, PP2. Interestingly, PP2 did not inhibit ®bronectin-stimulated migration of DU145 cells, and FRNK expression marginally inhibited such migration. These observations suggest that integrin engagement in DU145 cells stimulates additional pro-migratory signaling pathways, possibly including MAPK activation (Mainiero et al., 1997) that are independent of Src and/or FAK activity. However, chemokinesis and serum-stimulated chemotaxis of LNCaP, PC3 and DU145 cells as well as ®bronectin-stimulated haptotaxis of LNCaP and PC3 cells are dependent on FAK/Src signaling.
The mechanisms whereby FAK/Src signaling pathways regulate migration are largely unknown. Observations of migration defects in cells derived from FAK or Src/Fyn/Yes null embryos indicate the importance of these kinases (Ilic et al., 1995; Klinghoer et al., 1999; Owen et al., 1999; Sieg et al., 1999) . In addition, substrates of the FAK/Src bipartite kinase complex have been identi®ed as regulators of migration (Cary et al., 1998; Klemke et al., 1998; Petit et al., 2000) . Speci®cally, FAK/Srcmediated phosphorylation of Cas or paxillin creates binding sites for the adapter protein Crk (Hamasaki et al., 1996; Harte et al., 1996; Schaller and Parsons, 1995; Tachibana et al., 1997) , which binds to DOCK180 (Kiyokawa et al., 1998b; Matsuda et al., 1996; Posern et al., 1998) , an activator of Rac (Kiyokawa et al., 1998a; Nolan et al., 1998) , thereby directing Rac activity to sites of integrin engagement with the ECM to stimulate membrane ruing and cell migration (Cheresh et al., 1999; Hasegawa et al., 1996; Reddien and Horvitz, 2000; Wu and Horvitz, 1998) . Indeed, Cas over expression in FG carcinoma cells and Chinese hamster ovary cells stimulates motility (Cary et al., 1998; Klemke et al., 1998) . The lack of adhesiondependent regulation of Src activity in PC3 and DU145 cells could promote Rac activation in the absence of integrin signals resulting in increased migration.
The central role of FAK/Src signal transduction cascade in prostate carcinoma cell migration suggests potential therapeutic targets to inhibit tumor metastasis. The ability of FRNK over expression to down regulate FAK activity and potentially adhesiondirected Src activity make FRNK an ideal therapeutic tool. Studies are currently underway to address the ecacy of FRNK in blocking tumor metastasis.
Materials and methods

Reagents
LNCaP cells, a lymph node metastasis of prostatic adenocarcinoma (Horoszewicz et al., 1983; Wu et al., 1994) , and PC3 cells, derived from a bone marrow metastasis of prostatic adenocarcinoma (Kaighn et al., 1979) were kindly provided by L Chung, University of Virginia. Both lines were maintained in T media (Life Technologies, Inc.) supplemented with 5% fetal bovine serum (FBS). DU145 cells, derived from a brain metastasis (Stone et al., 1978) were obtained from ATCC and maintained in RPMI1640 supplemented with 10% FBS. Fibronectin was purchased from Sigma as a 1 mg/ml solution, and human laminin from Life Technologies, Inc. as a 0.6 mg/ml solution. Vitronectin was reconstituted in distilled water, aliquotted and stored at 7708C. The following antibodies were used for immunoprecipitation and Western blotting: FAK monoclonal antibody (mAb) 2A7 (Kanner et al., 1990) , phosphotyrosine mAb, 4G10 (Santa Cruz, Inc.), rabbit anti-human C-term FAK (Pharminogen, Inc.), species anti-N-term FAK (Santa Cruz, Inc.), anti-GAPDH (Sigma) and phosphorylation site speci®c rabbit anti-FAK p-Y397, p-Y576/577, p-Y861, p-Y925 (BioSourceQuality Controlled Biochemicals, Inc.). PP2 (Hanke et al., 1996) and the inactive congener PP3 (Calbiochem) were reconstituted in dimethylsulphoxide (DMSO).
Adenovirus constructs
Two recombinant type 5 adenoviruses, AdGFP and AdGFPtagged FRNK (GFP ± FRNK), were generated by PCR ampli®cation from pEGFP-C1 (Clontech) and pEGFP-C1-FRNK respectively using primers that added 5' and 3' BamHI restriction sites. The resultant PCR products were digested with BamHI and ligated with BamHI digest pAD-lox ( (Hardy et al., 1997) ; generously provided by Stephen Hardy, Somatix Therapy Corporation, Almeda, CA, USA). Correct orientations of all reading frames were con®rmed by sequencing and Western blot analysis of expressed proteins. Homologous recombination between the adenovirus vector and the shuttle vector was obtained by cotransfection of either GFPAd-lox or GFP-FRNKAd-lox with replicationdefective type 5 adenovirus in HEK293 cells that stably over express Cre-recombinase. Plaque puri®ed virus (1610 10 pfu/ ml) was generated and puri®ed by cesium-chloride gradients as described previously (Hardy et al., 1997) . We have shown previously equal expression of GFP and GFP ± FRNK following infection of mammalian cells (Taylor et al., 2000) .
Cell migration assays
Cell migration was assessed using modi®ed Boyden chambers (tissue culture treated, 6.5 mm diameter, 10 mm thickness, 8 mm pores, BioCoat, Becton Dickenson). Serum-containing media was placed in both the upper and lower chamber of each transwell to assess the requirement for cell migration. Haptotactic migration was assessed by coating the underside of the upper chamber with ®bronectin, human laminin, or vitronectin suspended in phosphate buered saline (PBS) for 16 h at 48C. The eects of PP2 on cell migration were determined by including the inhibitor in the Boyden chamber for the length of the assay. To assess the eect of FRNK over expression on migration of prostate carcinoma cell lines, 5 ± 7.5610 5 cells were infected for 6 h with adenovirus encoding GFP or GFP ± FRNK at a multiplicity of infection (MOI) of two for LNCaP cells or eight for PC3 and DU145 cells. These MOI values were determined to yield greater than 80% infection.
Migration assays were performed by platting 5610 4 continuously growing cells in the upper chamber of a Transwell and incubating for 24 h at 378C. Time course experiments demonstrated maximum migration of LNCaP cells at 24 h (data not shown). To compare migration among the prostate cell lines, the migration assay time was kept constant at 24 h. Non-migrating cells on the upper side of the membrane were removed with a cotton swab. Cells that had migrated to the underside of the membrane were ®xed with 4% paraformaldehyde at room temperature for 20 min and washed twice with PBS. To aid in visualization, uninfected cells were stained with 0.1% crystal violet at room temperature for 15 min, washed with PBS and distilled water, and allowed to air dry. Migration of uninfected cells was assessed by counting four 3206®elds of cells using Ziess Axiovert 135TV inverted¯uorescence microscope. For experiments using infected cells, the number of¯uorescent cells that migrated was determined by counting one 1006®eld using Ziess Axiovert 135TV inverted¯uorescence microscope. Each experiment was performed in triplicate and repeated at least three times. Statistical assessment of dierences in cell migration was performed using multi-factor analysis of variance (ANOVA) models ®t using maximum likelihood techniques. The natural logarithmic variancestabilizing transformation was required to meet assumptions of a linear model (constant variance and normally distributed error terms). Con®dence intervals for pair-wise dierences were generated by Fisher's Least Signi®cant Dierence method with comparison type I error rate of 5% (Hsu., 1996) .
Immunoprecipitation and Western blotting
LNCaP, PC3 or DU145 cells were harvested with 2 mM EDTA or trypsin-EDTA (followed by neutralization in soy bean trypsin inhibitor), kept in suspension for indicated periods of time and allowed to reattach to matrix coated dishes. Suspended cells or those that were allowed to reattach were lysed in supplemented RIPA buer (50 mM HEPES, 0.15 M NaCl, 2 mM EDTA, 0.1% nonidet P-40 and 0.05% sodium deoxycholate, pH 7.2) containing 1 mM PMSF, 100 mM leupeptin, and 0.05 TIU/ml aprotinin, 1 mM Na 3 VO 4 , 40 mM NaF, 10 mM Na 2 pyrophosphate. Attached cells were lysed directly on the plate in supplemented RIPA buer. FAK was immunoprecipitated by incubating 0.5 to 1.0 mg cell lysate with mAb 2A7 (Kanner et al., 1990) for 2 h at 48C. Protein ± antibody complexes were incubated for 1 h at 48C with protein A-Sepharose conjugated beads (Pharmacia) (preincubated with rabbit anti-mouse IgG), collected by centrifugation, washed three times with RIPA buer and once with TBS (10 mM Tris-HCl [pH 8.0], 150 mM NaCl), and boiled in Lammeli sample buer. The proteins were resolved on 8% SDS ± PAGE gels, transferred to nitrocellulose and blotted with the phosphotyrosine-speci®c mAb, 4G10 followed by horseradish peroxidase (HRP)-conjugated goat anti-mouse. The immunoblots were stripped at 508C for 30 min in stripping buer (100 mM b-mercaptoethanol, 2% SDS, 62.5 mM ) and blotted with mAb 2A7 followed by incubation with HRP-conjugated goat antimouse secondary antibodies and visualization by chemiluminescence (ECL, Amersham). Western analysis of whole cell lysates was performed using 50 ± 100 mg protein.
